| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
2023 American Thoracic Society International Conference
|
Venkatesan, Priya
|
|
|
11 |
7 |
p. e69-e71
|
artikel
|
| 2 |
Bronchiectasis: a global disease necessitating global solutions
|
Chotirmall, Sanjay H
|
|
|
11 |
7 |
p. 581-583
|
artikel
|
| 3 |
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)
|
Chalmers, James D
|
|
|
11 |
7 |
p. 637-649
|
artikel
|
| 4 |
Correction to Lancet Respir Med 2022; 10: e63–64
|
|
|
|
11 |
7 |
p. e68
|
artikel
|
| 5 |
Cough and cough hypersensitivity as treatable traits of asthma
|
Lai, Kefang
|
|
|
11 |
7 |
p. 650-662
|
artikel
|
| 6 |
Digital health in difficult-to-treat severe asthma
|
Busse, William W
|
|
|
11 |
7 |
p. 578-579
|
artikel
|
| 7 |
2023 GINA report for asthma
|
Venkatesan, Priya
|
|
|
11 |
7 |
p. 589
|
artikel
|
| 8 |
Intensive care unit delirium—a decade of learning
|
Kotfis, Katarzyna
|
|
|
11 |
7 |
p. 584-586
|
artikel
|
| 9 |
Katarzyna Kotfis—putting ICU delirium on the map
|
Kirby, Tony
|
|
|
11 |
7 |
p. 590
|
artikel
|
| 10 |
Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3)
|
Reignier, Jean
|
|
|
11 |
7 |
p. 602-612
|
artikel
|
| 11 |
Managing medical (mis)information
|
The Lancet Respiratory Medicine,
|
|
|
11 |
7 |
p. 577
|
artikel
|
| 12 |
NUTRIREA-3: where to next?
|
Ridley, Emma J
|
|
|
11 |
7 |
p. 580-581
|
artikel
|
| 13 |
Nutrition during the acute phase of critical illness: discussions on NUTRIREA-3
|
Patel, Jayshil J
|
|
|
11 |
7 |
p. e64
|
artikel
|
| 14 |
Nutrition during the acute phase of critical illness: discussions on NUTRIREA-3
|
Lee, Zheng-Yii
|
|
|
11 |
7 |
p. e62-e63
|
artikel
|
| 15 |
Nutrition during the acute phase of critical illness: discussions on NUTRIREA-3
|
Hartl, Wolfgang H
|
|
|
11 |
7 |
p. e61
|
artikel
|
| 16 |
Nutrition during the acute phase of critical illness: discussions on NUTRIREA-3 – Authors' reply
|
Reignier, Jean
|
|
|
11 |
7 |
p. e65
|
artikel
|
| 17 |
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial
|
Tang, Rong
|
|
|
11 |
7 |
p. 613-623
|
artikel
|
| 18 |
Sarcoidosis and fatigue: there is a useful cognitive treatment?
|
Carbone, Roberto G
|
|
|
11 |
7 |
p. e66
|
artikel
|
| 19 |
Sarcoidosis and fatigue: there is a useful cognitive treatment? – Authors' reply
|
Kahlmann, Vivienne
|
|
|
11 |
7 |
p. e67
|
artikel
|
| 20 |
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
|
Lu, Shun
|
|
|
11 |
7 |
p. 624-636
|
artikel
|
| 21 |
The future of childhood immunisation
|
Burki, Talha
|
|
|
11 |
7 |
p. e72
|
artikel
|
| 22 |
US CDC announces indoor air guidance for COVID-19 after 3 years
|
Furlow, Bryant
|
|
|
11 |
7 |
p. 587
|
artikel
|
| 23 |
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial
|
Hale, Elaine Mac
|
|
|
11 |
7 |
p. 591-601
|
artikel
|
| 24 |
WHO ends the COVID-19 public health emergency
|
Burki, Talha
|
|
|
11 |
7 |
p. 588
|
artikel
|
Tijdschrift beschrijving